) Unit: million Baht 2017 2016 Gr ou p Group Revenues 25,705 21,684 Group EBITDA 2,306 1,555 Group Net Profit (Loss) 365 (1,048) HR C HRC Sales (k tons) 1,381 1,326 HRC Production Volume (k tons) 1,429
Increase (Decrease) % Net Assets 6,724,090 6,229,084 495,006 7.95 Net Liabilities 2,078,079 1,365,378 712,702 52.20 Shareholders’ equity 4,646,010 4,863,707 (217,697) (4.48) Assets As at December 31, 2018
tick where applicable ): The index is recognized by a member of the World Federation of Exchange and the index constituents are eligible assets according to the Notification of the Capital Market
eligible assets according to the Notification of the Capital Market Supervisory Board concerning Investment of Funds. The index is in accordance with the principle-based guidelines (having a clearly defined
T A T E M E N T O F F I N A N C I A L P O S I T I O N Total AssetsA As of 31 March 2024, the total assets of the Company were THB 1,420 million, increased by THB 18 million or 1.3% from 31 December
January Subject To : Enclosu The Bo “Compa resoluti 1. A C 1 1 E 2. A r y 16, 2018 t : Notificat of New D Director an The Stock E ures : 1. Fo A 2. In (a oard of Dire any”) No. 1 ions as follo
www.interpharma.co.th IP_OCS/011/2020 8th June 2020 Subject: Notify the Resolutions of the Board of Directors Meeting, Change of Objectives of Funds Usage, Acquisition of Assets, The Issuance of Debentures and Fix the
of assets as a mutual fund (if any) shall be disclosed; (c) For which type of investment is the mutual fund a suitable choice? And for how long should investors invest in the mutual fund (in case the